Home/Filings/4/0000805928-21-000107
4//SEC Filing

Levine Alan M 4

Accession 0000805928-21-000107

CIK 0000805928other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 5:11 PM ET

Size

11.3 KB

Accession

0000805928-21-000107

Insider Transaction Report

Form 4
Period: 2021-06-01
Transactions
  • Exercise/Conversion

    Common Stock

    2021-06-01+6,1738,764 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-06-016,1730 total
    Common Stock (6,173 underlying)
  • Award

    Stock Option (right to buy)

    2021-06-01+6,0306,030 total
    Exercise: $19.76Exp: 2031-06-01Common Stock (6,030 underlying)
  • Award

    Restricted Stock Units

    2021-06-01+3,0363,036 total
    Common Stock (3,036 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
  • [F2]This reflects the number of restricted stock units that became vested as of June 1, 2021.
  • [F3]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

Issuer

Axogen, Inc.

CIK 0000805928

Entity typeother

Related Parties

1
  • filerCIK 0001766833

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:11 PM ET
Size
11.3 KB